Procter & Gamble Company (The) $PG Shares Sold by SouthState Corp

SouthState Corp reduced its stake in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 1.4% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 78,273 shares of the company’s stock after selling 1,106 shares during the period. SouthState Corp’s holdings in Procter & Gamble were worth $12,471,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Kingstone Capital Partners Texas LLC grew its position in Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Northern Trust Corp grew its position in shares of Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after acquiring an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. grew its position in shares of Procter & Gamble by 3.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock valued at $2,966,252,000 after acquiring an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Procter & Gamble by 6.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock valued at $2,947,146,000 after acquiring an additional 1,018,865 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the company. Raymond James Financial dropped their target price on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research report on Monday, October 20th. Morgan Stanley set a $175.00 target price on Procter & Gamble in a research report on Monday, October 27th. Barclays dropped their target price on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. UBS Group lowered their price objective on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Finally, Dbs Bank upgraded Procter & Gamble to a “moderate buy” rating in a research note on Tuesday, October 28th. Twelve analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average price target of $171.53.

Check Out Our Latest Report on Procter & Gamble

Procter & Gamble Stock Performance

PG opened at $145.79 on Thursday. Procter & Gamble Company has a twelve month low of $145.65 and a twelve month high of $180.43. The firm has a market capitalization of $340.67 billion, a PE ratio of 21.28, a PEG ratio of 3.87 and a beta of 0.36. The company has a current ratio of 0.71, a quick ratio of 0.51 and a debt-to-equity ratio of 0.46. The firm’s 50-day moving average price is $153.32 and its 200 day moving average price is $157.37.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.09. The business had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The business’s revenue was up 3.0% on a year-over-year basis. During the same period last year, the company posted $1.93 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, sell-side analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be paid a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a yield of 2.9%. Procter & Gamble’s payout ratio is 61.61%.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, CFO Andre Schulten sold 11,638 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the transaction, the chief financial officer owned 52,642 shares of the company’s stock, valued at approximately $8,279,007.34. The trade was a 18.11% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Gary A. Coombe sold 10,194 shares of the business’s stock in a transaction on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the transaction, the chief executive officer directly owned 34,978 shares in the company, valued at $5,532,120.48. This trade represents a 22.57% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 150,488 shares of company stock valued at $23,529,718 in the last three months. Company insiders own 0.20% of the company’s stock.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.